NO20065473L - IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati. - Google Patents

IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.

Info

Publication number
NO20065473L
NO20065473L NO20065473A NO20065473A NO20065473L NO 20065473 L NO20065473 L NO 20065473L NO 20065473 A NO20065473 A NO 20065473A NO 20065473 A NO20065473 A NO 20065473A NO 20065473 L NO20065473 L NO 20065473L
Authority
NO
Norway
Prior art keywords
chimeras
therapy
peripheral neuropathy
induced peripheral
chemotherapeutically
Prior art date
Application number
NO20065473A
Other languages
English (en)
Norwegian (no)
Inventor
Michel Revel
Judith Chebat
Hagit Krug
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO20065473L publication Critical patent/NO20065473L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20065473A 2004-04-29 2006-11-28 IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati. NO20065473L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL16167204A IL161672A0 (en) 2004-04-29 2004-04-29 Compositions and methods for therapy of chemotherapy-induced neuropathy
PCT/IL2005/000443 WO2005105134A1 (en) 2004-04-29 2005-04-28 Il6r/il6 chimera for therapy of chemotherapy-induced peripheral neuropathy

Publications (1)

Publication Number Publication Date
NO20065473L true NO20065473L (no) 2006-11-28

Family

ID=34074040

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065473A NO20065473L (no) 2004-04-29 2006-11-28 IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.

Country Status (9)

Country Link
US (1) US8394367B2 (es)
EP (1) EP1740199B1 (es)
JP (1) JP4778507B2 (es)
AU (1) AU2005237323A1 (es)
CA (1) CA2563849A1 (es)
ES (1) ES2444569T3 (es)
IL (2) IL161672A0 (es)
NO (1) NO20065473L (es)
WO (1) WO2005105134A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL163856A0 (en) * 2004-09-01 2005-12-18 Applied Research Systems Use of IL-6 in vascular complications
CN107779436A (zh) * 2017-10-27 2018-03-09 南京中医药大学 化疗所致周围神经病变细胞模型构建及其检测方法
CN114470189B (zh) * 2020-11-12 2024-01-16 达石药业(广东)有限公司 Ngf抗体在cipn性疼痛中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013095A1 (en) 1991-01-18 1992-08-06 Synergen, Inc. Methods for treating tumor necrosis factor mediated diseases
IT1247484B (it) 1991-03-22 1994-12-17 Ceinge Societa Consortile A R Metodo per la preparazione di interleuchina 6
IT1277926B1 (it) * 1995-09-01 1997-11-12 Angeletti P Ist Richerche Bio Uso di muteine di citochine naturali come immunogeni per la preparazione di composizioni farmaceutiche per curare o prevenire
DE19608813C2 (de) 1996-03-07 1998-07-02 Angewandte Gentechnologie Syst Konjugat zur Beeinflussung von Wechselwirkungen zwischen Proteinen
US6063758A (en) 1997-07-09 2000-05-16 Advanced Targeting Systems, Inc. Substance P-Saporin (SP-SAP) conjugates and methods of use thereof
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
US20020058628A1 (en) 1998-06-09 2002-05-16 Noble Mark David Antioxidants and intracellular glutathione raising agents for therapeutic treatments
US20040170604A1 (en) 1998-07-06 2004-09-02 Tosoh Corporation IL-6 receptor IL-6 direct fusion protein
DE69927375T2 (de) 1998-07-06 2006-06-22 Tosoh Corp., Shinnanyo Fusionsprotein mit direkter verknüpfung des il-6-rezeptors mit il-6
IL130586A0 (en) 1999-06-21 2000-06-01 Yeda Res & Dev IL6RIL6 chimera for the treatment of demyelinating diseases
ATE407697T1 (de) 1999-07-13 2008-09-15 Bolder Biotechnology Inc Erythropoietin immunglobulin fusionsproteine
KR20050035151A (ko) 2001-10-11 2005-04-15 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. 당뇨성 신경병증에서 ｇｐ130 활성인자의 용도

Also Published As

Publication number Publication date
EP1740199B1 (en) 2014-01-01
JP4778507B2 (ja) 2011-09-21
IL178635A0 (en) 2007-02-11
US20110274647A1 (en) 2011-11-10
EP1740199A1 (en) 2007-01-10
IL161672A0 (en) 2004-09-27
AU2005237323A1 (en) 2005-11-10
US8394367B2 (en) 2013-03-12
JP2007534745A (ja) 2007-11-29
IL178635A (en) 2014-01-30
ES2444569T3 (es) 2014-02-25
WO2005105134A1 (en) 2005-11-10
CA2563849A1 (en) 2005-11-10

Similar Documents

Publication Publication Date Title
NL301145I2 (nl) Tirbanibulin
CY1122522T1 (el) Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
DE602004026113D1 (de) Glp-1-verbindungen
DK1773885T3 (da) Humaniserede anti-c-met-antagonister
NO20082473L (no) Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander
DK3530673T3 (da) Humaniserede anti-beta7-antagonister og anvendelser deraf
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
BRPI0510674A (pt) variantes fc otimizadas
UA94221C2 (en) Lipocalin protein
EA201300246A1 (ru) Ингибиторы тирозинкиназы брутона
EA201301072A1 (ru) Антитела против il-23p19 и их применение
BRPI0511111A (pt) compostos de pirrol como inibidores de cinase de proteìna de erk, sua sìntese e seus intermediários
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE469658T1 (de) Kombinationstherapien gegen multiple toll-like- rezeptoren und ihre verwendung
BRPI0518228A (pt) inibidores de cinesina mitótica e métodos de uso destes
NO20091064L (no) Antistoffer mot IL-17A
UA85559C2 (en) Aminobenzophenone compounds
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
EA200700717A1 (ru) Сульфонамиды
BRPI0517799A (pt) composição para facilitar o parto humano
ATE448232T1 (de) Substituierte heterozyklen
EA200800206A1 (ru) Комбинированное применение метконазола и эпоксиконазола для уменьшения или предотвращения заражения зерновых культур микотоксинами
SG158133A1 (en) Method for reversing multiple resistance in animal cells

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application